cE3c-Centro de Ecologia, Evolução e Alterações Ambientais, Faculdade de Ciências, Universidade de Lisboa, Lisbon, Portugal.
Institut de Systématique, Evolution, Biodiversité (ISYEB), Muséum National d'Histoire Naturelle, CNRS, Sorbonne Université, EPHE, Paris, France.
mSphere. 2019 May 1;4(3):e00135-19. doi: 10.1128/mSphere.00135-19.
Human beings have used large amounts of antibiotics, not only in medical contexts but also, for example, as growth factors in agriculture and livestock, resulting in the contamination of the environment. Even when pathogenic bacteria are the targets of antibiotics, hundreds of nonpathogenic bacterial species are affected as well. Therefore, both pathogenic and nonpathogenic bacteria have gradually become resistant to antibiotics. We tested whether there is still cooccurrence of resistance and virulence determinants. We performed a comparative study of environmental and human gut metagenomes from different individuals and from distinct human populations across the world. We found a great diversity of antibiotic resistance determinants (AR diversity [ARd]) and virulence factors (VF diversity [VFd]) in metagenomes. Importantly there is a correlation between ARd and VFd, even after correcting for protein family richness. In the human gut, there are less ARd and VFd than in more diversified environments, and yet correlations between the ARd and VFd are stronger. They can vary from very high in Malawi, where antibiotic consumption is unattended, to nonexistent in the uncontacted Amerindian population. We conclude that there is cooccurrence of resistance and virulence determinants in human gut microbiomes, suggesting a possible coselective mechanism. Every year, thousands of tons of antibiotics are used, not only in human and animal health but also as growth promoters in livestock. Consequently, during the last 75 years, antibiotic-resistant bacterial strains have been selected in human and environmental microbial communities. This implies that, even when pathogenic bacteria are the targets of antibiotics, hundreds of nonpathogenic bacterial species are also affected. Here, we performed a comparative study of environmental and human gut microbial communities issuing from different individuals and from distinct human populations across the world. We found that antibiotic resistance and pathogenicity are correlated and speculate that, by selecting for resistant bacteria, we may be selecting for more virulent strains as a side effect of antimicrobial therapy.
人类大量使用抗生素,不仅在医疗环境中,而且例如在农业和畜牧业中作为生长促进剂,导致环境受到污染。即使抗生素的靶标是病原菌,也有数百种非病原菌受到影响。因此,病原菌和非病原菌都逐渐对抗生素产生了耐药性。我们测试了是否仍然存在耐药性和毒力决定因素的共同发生。我们对来自不同个体和来自世界各地不同人群的环境和人类肠道宏基因组进行了比较研究。我们在宏基因组中发现了丰富的抗生素耐药决定因素(AR 多样性 [ARd])和毒力因子(VF 多样性 [VFd])。重要的是,即使在纠正了蛋白质家族丰富度之后,ARd 和 VFd 之间仍然存在相关性。在人类肠道中,ARd 和 VFd 的数量比多样化环境中的少,但 ARd 和 VFd 之间的相关性更强。从抗生素使用不受关注的马拉维,到与世隔绝的美洲印第安人群体,两者之间的相关性可能非常高,也可能不存在。我们的结论是,人类肠道微生物组中存在耐药性和毒力决定因素的共同发生,这表明可能存在共选择机制。每年都有数千吨抗生素不仅用于人类和动物健康,还用于畜牧业中的生长促进剂。因此,在过去的 75 年中,抗生素耐药细菌株在人类和环境微生物群落中被选择。这意味着,即使抗生素的靶标是病原菌,也有数百种非病原菌受到影响。在这里,我们对来自不同个体和来自世界各地不同人群的环境和人类肠道微生物群落进行了比较研究。我们发现抗生素耐药性和致病性相关,并推测通过选择耐药细菌,我们可能会选择更具毒力的菌株作为抗菌治疗的副作用。